Viability and effectiveness of large-scale HIV treatment initiatives in sub-Saharan Africa: experience from western Kenya.
about
Estimating the capacity for ART provision in Tanzania with the use of data on staff productivity and patient lossesImpact of drug stock-outs on death and retention to care among HIV-infected patients on combination antiretroviral therapy in Abidjan, Côte d'IvoireCost-effectiveness of preventing loss to follow-up in HIV treatment programs: a Côte d'Ivoire appraisalA randomized controlled trial comparing the effects of counseling and alarm device on HAART adherence and virologic outcomesMonitoring HIV viral load in resource limited settings: still a matter of debate?The ESTHER hospital partnership initiative: a powerful levy for building capacities to combat the HIV pandemic in low-resource countriesThe role of emergency department HIV care in resource-poor settings: lessons learned in western KenyaThe evolution of diabetes care in the rural, resource-constrained setting of western Kenya.Medical Education and Training: Building In-Country Capacity at All Levels.Novel Approaches for Visualizing and Analyzing Dose-Timing Data from Electronic Drug Monitors, or "How the 'Broken Window' Theory Pertains to ART Adherence".Viewpoint: a pragmatic approach to constructing a minimum data set for care of patients with HIV in developing countries.Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South AfricaPatient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic reviewOverestimates of survival after HAART: implications for global scale-up effortsGood adherence to HAART and improved survival in a community HIV/AIDS treatment and care programme: the experience of The AIDS Support Organization (TASO), Kampala, Uganda.Sampling-based approaches to improve estimation of mortality among patient dropouts: experience from a large PEPFAR-funded program in Western Kenya.Measuring adherence to antiretroviral treatment in resource-poor settings: the clinical validity of key indicators.Measuring adherence to antiretroviral treatment in resource-poor settings: the feasibility of collecting routine data for key indicators.The "ART" of linkage: pre-treatment loss to care after HIV diagnosis at two PEPFAR sites in Durban, South Africa.A cluster randomized trial of routine HIV-1 viral load monitoring in Zambia: study design, implementation, and baseline cohort characteristics.Choosing profile double-sampling designs for survival estimation with application to President's Emergency Plan for AIDS Relief evaluation.Long term outcomes of antiretroviral therapy in a large HIV/AIDS care clinic in urban South Africa: a prospective cohort study.Low haemoglobin predicts early mortality among adults starting antiretroviral therapy in an HIV care programme in South Africa: a cohort studyEffect of pulmonary tuberculosis on mortality in patients receiving HAART.Adjusting mortality for loss to follow-up: analysis of five ART programmes in sub-Saharan Africa.An empirical approach to defining loss to follow-up among patients enrolled in antiretroviral treatment programsConsistent ART adherence is associated with improved quality of Life, CD4 counts, and reduced hospital costs in central China.Methods and baseline results of a repeated cross-sectional survey to assess the public health impact of antiretroviral therapy in Lusaka, ZambiaFour-year treatment outcomes of adult patients enrolled in Mozambique's rapidly expanding antiretroviral therapy program.Risk factors for non-adherence and loss to follow-up in a three-year clinical trial in BotswanaRetention in care and connection to care among HIV-infected patients on antiretroviral therapy in Africa: estimation via a sampling-based approachCD4 trajectory adjusting for dropout among HIV-positive patients receiving combination antiretroviral therapy in an East African HIV care centre.Universal definition of loss to follow-up in HIV treatment programs: a statistical analysis of 111 facilities in Africa, Asia, and Latin America.The need for double-sampling designs in survival studies: an application to monitor PEPFARCharacteristics of psychosocial support seeking during HIV-related treatment in western KenyaInfluence of gender on loss to follow-up in a large HIV treatment programme in western Kenya.Mobile phones to support adherence to antiretroviral therapy: what would it cost the Indian National AIDS Control Programme?An assessment of the accuracy and availability of data in electronic patient tracking systems for patients receiving HIV treatment in central Mozambique.In the shadowlands of global health: observations from health workers in Kenya.Delivery of HIV care during the 2007 post-election crisis in Kenya: a case study analyzing the response of the Academic Model Providing Access to Healthcare (AMPATH) program
P2860
Q21143796-AC3520BA-C805-4A1E-9763-9642C52E11D9Q28475790-FBAF77EB-8F0A-4F6E-80EE-720B292D3198Q28476337-6F8793E4-E03E-4ABF-A819-8EE4D2990855Q28477310-6D5D8DAC-5656-4ED9-A5F6-6DE411D86609Q28485511-23B3FA98-E9B7-43B4-A891-C232B7F1651DQ28601430-F63B0BD5-E06E-4AC7-94F3-549AD830D2CDQ30376333-23453DF5-6205-4A80-96AC-DB8FDE9CEC1FQ30402488-AB756F87-3F59-4184-9556-49B3F8731D85Q30824688-140C9AF5-C01B-485F-97F2-3A261F4C2D6CQ30936928-B23F16F2-AA99-44BA-A01D-83B72CFCE460Q31033012-8F0EEC9D-0492-4E5F-8FB0-4D2977C2801AQ33279183-20E9B1E0-B1E2-4E1F-AE1E-83C227582DB1Q33302944-DDC2D52E-72E7-4265-B797-997D06C1F9F0Q33322531-4677CCCA-9A49-4D58-86C1-01E6B3FE0B4BQ33385849-FA231ADD-BBE2-4873-937A-1C6C1D2A6F6EQ33388709-3C51BA88-F980-4D78-8DEE-D6C0042379F4Q33532758-3ECB268B-2B08-4655-9C3F-8EF0CE22828DQ33532759-128FF490-6552-4685-B2B1-3A5D0684DA1CQ33537984-D855BCCC-0F6D-4D18-A31D-A1813BD51744Q33543151-B5B229D5-4977-49C7-BB6E-48145E5CA9C6Q33578888-5FD0D49A-84F8-4853-81EB-9FB46FBBA7F0Q33609257-881A1D17-627C-40B6-85D4-71F39AFE06B4Q33638969-250AEE81-5E14-423A-AC20-127367CE9C86Q33764880-80372A44-5EAD-40AE-B2E6-777B0949ACEBQ33770158-7CEFFA71-F010-407E-B4EF-D24CA7FDA64EQ33774697-83D8BE40-55A9-4339-A662-C7D491AF4F47Q33807634-CFF575CD-1D85-495C-8E2E-CEFD19E35A93Q33817536-331159A0-726F-49E1-AEA7-13EC0FF6D545Q33869315-4608532C-3214-4658-A3A9-5AC0A1F55529Q33889133-8AB19CD8-731F-4238-93BA-25ADF78CC766Q33982933-596DCEB1-2100-4AEB-821A-F38C1B14C823Q34059861-5C72CE82-DF01-401F-899B-59EC684A774AQ34062163-5C2EAA6A-23CA-4B52-BB5C-96F9C304B728Q34065148-9E5234E9-326E-486B-A29B-B3456BCB75FBQ34087761-9B956D4E-30A2-47B7-B885-88A02CE87109Q34092713-D9781C06-15BC-4134-85ED-661699EB819CQ34131243-A9716E57-C6CD-479C-8094-83373B5FE70FQ34148314-13BCD55C-878E-411F-A4D8-4F16A1826AB3Q34201796-3830E151-B26C-42F1-BA95-D8F469E3D33FQ34250217-AE1AE24A-B86B-48B9-BE55-E801DD968715
P2860
Viability and effectiveness of large-scale HIV treatment initiatives in sub-Saharan Africa: experience from western Kenya.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Viability and effectiveness of ...... experience from western Kenya.
@en
Viability and effectiveness of ...... experience from western Kenya.
@nl
type
label
Viability and effectiveness of ...... experience from western Kenya.
@en
Viability and effectiveness of ...... experience from western Kenya.
@nl
prefLabel
Viability and effectiveness of ...... experience from western Kenya.
@en
Viability and effectiveness of ...... experience from western Kenya.
@nl
P2093
P50
P1433
P1476
Viability and effectiveness of ...... experience from western Kenya.
@en
P2093
Abraham Siika
John Sidle
Kenneth H Fife
Lameck Diero
Robert Einterz
Silvester Kimaiyo
William M Tierney
P356
10.1097/01.AIDS.0000196177.65551.EA
P407
P577
2006-01-01T00:00:00Z